ClinicalTrials.gg
RecruitingNCT07628218Updated Oct 14, 2026

Video-Based Versus Physician-Led Exercise Training for Plantar Fasciitis

An interventional study of Physician-Led Face-to-Face Exercise Instruction and Video-Based Exercise Instruction in Plantar Fasciitis of Both Feet and Plantar Fascitis, sponsored by Balikesir Ataturk City Hospital. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Balikesir Ataturk City Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Feb 2026, registered May 2026).
  • Started Feb 2026; still recruiting 9 months later.
Updated Oct 14, 2026Study contact changed1 site addedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 42 studies in Fasciitis, Plantar with a site in Turkey — 15 open to participants now, 16 under way, none of them phase 3. Fasciitis, Plantar · Turkey.

Planned enrollment
Largest of 28
300 · median 57
Started
2026
with 8 others
No phase
28 of 42
10 open now
Primary completion
2026-11
later than 8 of 15 live
Registered
32nd of 42
by date

Among the 42 studies in Fasciitis, Plantar with a site in Turkey, this one has the largest planned enrollment of the 28 interventional ones that give a count, is one of 9 that started in 2026, is one of 28 with no phase, reaches primary completion later than 8 of the 15 other live ones, and was the 32nd registered.

Fasciitis, Plantar

224 studies on the registry are indexed under Fasciitis, Plantar; 59 are open to participants now.

Browse Fasciitis, Plantar studies →

Open to participants now

15 of the 42 studies in Fasciitis, Plantar with a site in Turkey are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 29 Fasciitis, Plantar studies recruiting now, 5 (17%) set no upper age limit and 21 (72%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Fasciitis, Plantar with a site in Turkey, or all of them as a file.
02

Study summary

This prospective, single-center, two-arm, parallel-group randomized non-inferiority trial will compare physician-led face-to-face exercise instruction with standardized video-based exercise instruction in adults with plantar fasciitis. Participants will be randomized in a 1:1 ratio to receive either face-to-face exercise training by an orthopedic physician or access to a standardized exercise video via QR code/web link. The exercise content will be identical in both groups; only the method of instruction will differ. The primary outcome will be the change in the Foot Function Index total/index score from baseline to 3 months. Secondary outcomes will include pain score, Foot Function Index subscales, exercise knowledge, exercise adherence, education time, video viewing status, additional treatment requirement, and patient satisfaction.

Read the detailed description

Plantar fasciitis is a common cause of chronic plantar heel pain and may lead to functional limitation and reduced quality of life. Exercise education is an important component of conservative treatment; however, in busy outpatient settings, the time available for detailed face-to-face instruction may be limited. Standardized video-based education may provide a practical alternative by delivering the same exercise content in a reproducible format.

This study will evaluate whether video-based exercise instruction is non-inferior to physician-led face-to-face instruction in patients with plantar fasciitis. All participants will receive standard information about plantar fasciitis, load management, footwear recommendations, weight control, short-term analgesic or anti-inflammatory use when needed, and heel pad or insole support. The home exercise program will be identical in both groups and will include plantar fascia-specific stretching, gastrocnemius/soleus stretching, plantar fascia self-massage, gradual toe raises, and towel pull exercises.

Assessments will be performed at baseline, 1 month, and 3 months after randomization. Functional status will be assessed using the Foot Function Index, and pain will be measured using a 0-10 numerical rating scale. Exercise knowledge, adherence, education duration, video viewing behavior, additional treatment use, and satisfaction will also be recorded.

03

Conditions studied

  • Plantar Fasciitis of Both Feet
  • Plantar Fascitis

Browse trials for

Keywords

  • Exercise Therapy
  • Patient Education
  • Non-Inferiority Trial
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 70 years
  • Clinical diagnosis of plantar fasciitis
  • Plantar heel pain lasting for at least 3 months
  • Heel pain that is most prominent with the first steps in the morning or after rest
  • Tenderness on palpation of the medial calcaneal tubercle
  • Baseline heel pain score of 4 or higher on a 0-10 numerical rating scale
  • Functional capacity to perform the prescribed exercises
  • Access to a smartphone, tablet, or computer to view the exercise video
  • Ability to provide written

Exclusion criteria

Exclusion Criteria:

  • Previous foot or ankle surgery on the affected side
  • History of foot fracture, foot tumor, advanced neuropathy, Charcot arthropathy, or tarsal tunnel syndrome
  • injection, extracorporeal shock wave therapy, -rich plasma injection, or other interventional treatment for plantar fasciitis within the last 6 months
  • Inflammatory arthritis or systemic rheumatologic disease affecting the foot
  • Severe knee or hip osteoarthritis limiting exercise performance
  • Severe cognitive impairment preventing participation or completion of questionnaires
  • Pregnancy
  • Inability or unwillingness to comply with the study protocol
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Platelets

Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Active comparator
    Physician-Led Face-to-Face Exercise Instruction

    Participants in this arm will receive standard plantar fasciitis education and physician-led face-to-face instruction of the home exercise program. The orthopedic physician will explain and demonstrate the exercises during the baseline visit. The exercise program will include plantar fascia-specific stretching, gastrocnemius/soleus stretching, plantar fascia self-massage, gradual toe raises, and towel pull exercises.

    Behavioral: Physician-Led Face-to-Face Exercise Instruction

  • Experimental
    Video-Based Exercise Instruction

    Participants in this arm will receive standard plantar fasciitis education and a QR code or web link providing access to a standardized exercise video prepared by the study team. The video will not be watched in the outpatient clinic; participants will be instructed to perform the exercises at home by watching the video. The exercise content, order, repetitions, and frequency will be identical to the physician-led group.

    Behavioral: Video-Based Exercise Instruction

Interventions

  • BehavioralPhysician-Led Face-to-Face Exercise Instruction

    Face-to-face instruction and demonstration of a standardized home exercise program by an orthopedic physician. The program includes plantar fascia-specific stretching, gastrocnemius/soleus stretching, plantar fascia self-massage, gradual toe raises, and towel pull exercises.

  • BehavioralVideo-Based Exercise Instruction

    Access to a standardized home exercise video prepared by the study team via QR code or web link. Participants will be instructed to watch the video at home and perform the same exercise program used in the physician-led group.

06

What researchers measure

Primary outcomes

  1. Change in Foot Function Index Total/Index Score From Baseline to 3 Months

    The Foot Function Index total/index score is a patient-reported measure of foot pain, disability, and activity limitation, converted to a 0-100 score. Higher scores indicate worse foot-related function. The primary endpoint will be the change from baseline to 3 months, calculated as baseline FFI score minus 3-month FFI score; higher positive values indicate greater clinical improvement.

    Time frame: Baseline and 3 months after randomization

Secondary outcomes

  1. Change in Numeric Rating Scale Pain Score From Baseline to 1 and 3 Months

    Heel pain while walking during the previous week will be assessed using an 11-point numerical rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates unbearable pain. Change scores will be calculated from baseline to each follow-up visit.

    Time frame: Baseline, 1 month, and 3 months after randomization

  2. Change in Foot Function Index Pain Subscale Score From Baseline to 1 and 3 Months

    The pain subscale of the Foot Function Index will be used to assess foot-related pain. Scores will be converted according to the standard Foot Function Index scoring method; higher scores indicate worse pain.

    Time frame: Baseline, 1 month, and 3 months after randomization

  3. Change in Foot Function Index Disability Subscale Score From Baseline to 1 and 3 Months

    The disability subscale of the Foot Function Index will be used to assess foot-related functional disability. Higher scores indicate greater disability.

    Time frame: Baseline, 1 month, and 3 months after randomization

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared because the ethics approval and informed consent do not include public sharing of participant-level data. De-identified aggregate study results will be reported in scientific presentations and publications.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Nov 2026, 9 months after the start.

Of 104 non-industry interventional studies with no phase under Fasciitis, Plantar, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 21. This study's planned 9 months is below that.

Counting every sponsor, half of 109 studies reached it within 11 months; a quarter within 6 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2026
First posted
Jun 4, 2026
StartActual
Feb 12, 2026
Primary completionEst.
Nov 12, 2026
CompletionEst.
Nov 12, 2026
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added
Show site
  • Balıkesir Atatürk City Hospital · Balıkesir, Turkey (Türkiye)
Oct 14, 2026
Contact
Study contact changed: g•••@hotmail.com · •••3113→g•••@hotmail.com · •••3113; added g•••@hotmail.com · •••3113. See the current contact
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    1 site added
    Show site
    • Balıkesir Atatürk City Hospital · Balıkesir, Turkey (Türkiye)
    Contact Study contact changed: g•••@hotmail.com · •••3113→g•••@hotmail.com · •••3113; added g•••@hotmail.com · •••3113. See the current contact
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07628218
Lead sponsor
Balikesir Ataturk City Hospital
Responsible party
güneş sarıkaya (Orthopedics and Traumatology Specialist, Balikesir Ataturk City Hospital) — Principal investigator
First posted
Jun 4, 2026
Start date
Feb 12, 2026
Primary completion
Nov 12, 2026 (estimated)
Completion
Nov 12, 2026 (estimated)
Last update
Oct 14, 2026

Study contacts

Güneş SARIKAYA, ortopedic surgeon
Contact
gunessarikaya05@hotmail.com
905436733113
Güneş SARIKAYA, ortopedic surgeon
Contact
gunessarikaya05@hotmail.com
05436733113
Güneş SARIKAYA
principal investigator · Balikesir Ataturk City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion